NFKB1 and osteoporosis: Recently, Bo Yu et al., showed that WNT4 enhances bone formation and inhibits osteoclast formation and inflammation in osteoporosis and skeletal aging mouse models by inhibiting nuclear factor‐kB (NF‐kB) via β‐catenin‐independent signalling [S12].